Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients
Jesús Troya(Hospital Universitario Infanta Leonor), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Ángela Casquero, Manuel L. Fernández-Guerrero(Hospital Universitario Fundación Jiménez Díaz)
Cited by 35
Related Papers
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
|Proceedings of the National Academy of Sciences|2022|198
Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators
|The Journal of Infectious Diseases|2007|173
Hospital-Acquired Infectious Endocarditis Not Associated with Cardiac Surgery: An Emerging Problem
|Clinical Infectious Diseases|1995|170